Abstract 3969: CTCs and CTC clusters in breast cancer patient-derived xenograft models
Debashish Sahay(University of Houston), Meghana V. Trivedi(University of Houston), Rachel Schiff(Baylor College of Medicine), Michael T. Lewis(Baylor College of Medicine), C. Kent Osborne(Texas Oncology), Lacey E. Dobrolecki(Baylor College of Medicine), Agostina Nardone(AstraZeneca (Spain)), Jackie L. Stilwell(ViaCyte (United States)), Mothaffar F. Rimawi(Baylor College of Medicine), Raksha R. Bhat(University of Houston), Arturo B. Ramirez, Eric Kaldjian(Seattle University)
Cited by 0
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853